2 ASX shares to buy for a post-pandemic world

Here's why I would buy these ASX shares, including CSL Limited (ASX: CSL), for a post-pandemic ASX world.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The coronavirus pandemic has turned the world of investing (as well as most other worlds) upside down. Although the S&P/ASX 200 Index (ASX: XJO) and the broader markets have substantially recovered from the lows we saw in March, it's still a difficult landscape in which to choose ASX shares for one's own portfolio.

We still don't know exactly which companies will be affected by the coronavirus shutdowns, how long they will be affected for and how long it will take for things to return to 'normal'.

Despite my belief that a strong recovery will eventually come, I think it's fairly safe to say that the economy won't look quite the same as it did before the pandemic struck.

So here are 2 ASX shares that I think will make great investments in a post-pandemic world:

CSL Limited (ASX: CSL)

CSL is the largest company on the ASX – and for good reason. It has grown at such a rate that its shares have more than tripled in value over the past 5 years. CSL is a leader in the global blood medicine and vaccination fields. CSL has been called upon before by the Australian government to manufacture large batches of vaccines when Swine Flu was emerging as a threat a few years ago – and its services might be required again if a vaccine for COVID-19 is found.

In fact, just today it was announced that CSL is working on an immunoglobulin therapy that has the potential to help individuals who have contracted the disease. All in all, I think CSL is a winning company – rain, hail or shine.

Ramsay Health Care Limited (ASX: RHC)

Ramsay is the largest operator of private hospitals in Australia and also has a significant global presence with its operations in the UK, Indonesia and France.

This company hasn't escaped unscathed from the coronavirus crisis – suffering when the government banned all non-essential elective surgeries in preparation for the pandemic. As a result, it initiated a capital raising and suspended its dividend payments – ending a 20-year streak for the latter.

Still, I think this company has a bright post-pandemic future. As long as the coronavirus is still around, Ramsay will be playing an important role in treatment. And once we enter a post-pandemic world, the ageing demographics of our population give Ramsay a strong tailwind and should ensure its top-notch hospitals remain in strong demand for decades to come.

Sebastian Bowen owns shares of Ramsay Health Care Limited. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia has recommended Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

3 small-cap ASX healthcare shares 'with strong prospects'

Fund manager IML discusses why these 3 ASX healthcare shares are likely to rise in value.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

2 All Ords ASX healthcare shares making BIG moves on quarterly updates

These two ASX healthcare companies are seeing heavy trading on Thursday.

Read more »

A woman reclines in a comfortable chair while she donates blood holding a pumping toy in one hand and giving the thumbs up in the other as she is attached to a medical machine to collect her blood donation.
Healthcare Shares

'Trading at a discount': Why now is the time to buy CSL shares

This investing expert says CSL shares now represent an appealing buying opportunity.

Read more »

woman testing substance in laboratory dish, csl share price
Healthcare Shares

Here's what could impact CSL shares from the biotech's AGM

The biotech giant's leadership had plenty to say.

Read more »

Man with a sleep apnoea mask on whilst sleeping.
Healthcare Shares

Why this fundie is backing ResMed shares in FY25

There's plenty more upside, this fund says.

Read more »

A young man punches the air in delight as he reacts to great news on his mobile phone.
Healthcare Shares

ResMed shares jump 8% on stellar start to FY25

This high-quality company continues to deliver the goods.

Read more »

Senior woman with caregiver in the garden
Healthcare Shares

A 'golden era' is coming for these ASX healthcare shares

Here's why Blackwattle Partners sees tailwinds ahead for one particular category of healthcare shares.

Read more »

Two lab workers fist pump each other.
Healthcare Shares

Guess which ASX 200 healthcare stock is rising on big FDA news

Some big news is giving this stock a major lift on Thursday.

Read more »